Appleton Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,643
| Closed | -$220K | – | 41 |
|
|
2023
Q2 | $220K | Buy |
+2,643
| New | +$220K | 0.31% | 33 |
|
|
2022
Q3 | – | Sell |
-3,531
| Closed | -$262K | – | 30 |
|
|
2022
Q2 | $262K | Buy |
+3,531
| New | +$262K | 1.52% | 22 |
|
|
2021
Q4 | – | Sell |
-2,097
| Closed | -$264K | – | 58 |
|
|
2021
Q3 | $264K | Buy |
2,097
+38
| +2% | +$4.78K | 0.23% | 42 |
|
|
2021
Q2 | $279K | Buy |
+2,059
| New | +$279K | 0.21% | 48 |
|
|
2021
Q1 | – | Sell |
-2,101
| Closed | -$296K | – | 51 |
|
|
2020
Q4 | $296K | Buy |
+2,101
| New | +$296K | 0.29% | 19 |
|
|
2020
Q3 | – | Sell |
-3,438
| Closed | -$385K | – | 33 |
|
|
2020
Q2 | $385K | Buy |
+3,438
| New | +$385K | 0.46% | 17 |
|
|
2020
Q1 | – | Sell |
-3,977
| Closed | -$378K | – | 27 |
|
|
2019
Q4 | $378K | Buy |
+3,977
| New | +$378K | 0.48% | 24 |
|
|
2019
Q2 | – | Sell |
-5,022
| Closed | -$455K | – | 31 |
|
|
2019
Q1 | $455K | Buy |
+5,022
| New | +$455K | 0.44% | 26 |
|
|
2018
Q4 | – | Sell |
-9,712
| Closed | -$931K | – | 25 |
|
|
2018
Q3 | $931K | Buy |
9,712
+149
| +2% | +$14.3K | 0.99% | 14 |
|
|
2018
Q2 | $910K | Buy |
9,563
+38
| +0.4% | +$3.62K | 1.2% | 12 |
|
|
2018
Q1 | $836K | Buy |
9,525
+1,286
| +16% | +$113K | 0.96% | 15 |
|
|
2017
Q4 | $699K | Sell |
8,239
-269
| -3% | -$22.8K | 0.69% | 21 |
|
|
2017
Q3 | $737K | Buy |
8,508
+375
| +5% | +$32.5K | 0.79% | 18 |
|
|
2017
Q2 | $628K | Buy |
8,133
+1,585
| +24% | +$122K | 0.71% | 18 |
|
|
2017
Q1 | $454K | Buy |
6,548
+2,580
| +65% | +$179K | 0.52% | 21 |
|
|
2016
Q4 | $235K | Buy |
3,968
+526
| +15% | +$31.2K | 0.31% | 26 |
|
|
2016
Q3 | $228K | Buy |
+3,442
| New | +$228K | 0.28% | 27 |
|
|
2015
Q3 | – | Sell |
-2,472
| Closed | -$208K | – | 29 |
|
|
2015
Q2 | $208K | Buy |
+2,472
| New | +$208K | 0.24% | 23 |
|